Share in X

Carrier Screening Market Size, Scope, Revenue Report 2026 to 2035

Report ID: 3647 Pages: 180 Updated: 17 July 2026 Format: PDF / PPT / Excel / Power BI

Market Segmentation:

Carrier Screening Market by Medical Conditions - 

• Spinal Muscular Atrophy
• Cystic Fibrosis
• Tay-Sachs
• Gaucher Disease
• Sickle Cell Disease
• Others

Carrier Screening Market seg

Carrier Screening Market by Type -

• Expanded Carrier Screening
• Targeted Disease Carrier Screening

Carrier Screening Market by Technology -

• DNA Sequencing
• Polymerase Chain Reaction
• Microarrays
• Other Technologies (MLPA, Genotyping, Enzyme Screening)

Carrier Screening Market by End Use-

• Hospitals
• Laboratories
• Physician Offices & Clinics
• Other End Users

Carrier Screening Market by Region-

North America-

• The US
• Canada
• Mexico

Europe-

• Germany 
• The UK
• France
• Italy 
• Spain 
• Rest of Europe

Asia-Pacific-

• China
• Japan 
• India
• South Korea
• South East Asia
• Rest of Asia Pacific

Latin America-

• Brazil
• Argentina
• Rest of Latin America

Middle East & Africa-

• GCC Countries
• South Africa 
• Rest of Middle East and Africa

Chapter 1. Methodology and Scope

1.1. Research Methodology
1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Carrier Screening Market Snapshot

Chapter 4. Global Carrier Screening Market Variables, Trends & Scope

4.1. Market Segmentation & Scope
4.2. Market Drivers
4.3. Market Challenges
4.4. Market Trends
4.5. Regulatory Landscape
4.6. Reimbursement Analysis
4.7. Porter’s Five Forces Analysis
4.8. Incremental Opportunity Analysis (US$ Mn), 2025–2035
4.9. Market Penetration & Growth Prospect Mapping (US$ Mn), 2026–2035
4.10. Competitive Landscape & Market Share Analysis, 2026
4.11. Impact of Next-Generation Sequencing on Carrier Screening

Chapter 5. Market Segmentation 1: By Medical Conditions

5.1. Market Share, 2025 & 2035
5.2. Market Size (US$ Mn), 2022–2035

5.2.1. Spinal Muscular Atrophy
5.2.2. Cystic Fibrosis
5.2.3. Tay-Sachs
5.2.4. Gaucher Disease
5.2.5. Sickle Cell Disease
5.2.6. Others

Chapter 6. Market Segmentation 2: By Type

6.1. Market Share, 2025 & 2035
6.2. Market Size (US$ Mn), 2022–2035

6.2.1. Expanded Carrier Screening
6.2.2. Targeted Disease Carrier Screening

Chapter 7. Market Segmentation 3: By Technology

7.1. Market Share, 2025 & 2035
7.2. Market Size (US$ Mn), 2022–2035

7.2.1. DNA Sequencing
7.2.2. Polymerase Chain Reaction (PCR)
7.2.3. Microarrays
7.2.4. Other Technologies (MLPA, Genotyping, Enzyme Screening)

Chapter 8. Market Segmentation 4: By End Use

8.1. Market Share, 2025 & 2035
8.2. Market Size (US$ Mn), 2022–2035

8.2.1. Hospitals
8.2.2. Laboratories
8.2.3. Physician Offices & Clinics
8.2.4. Other End Users

Chapter 9. Regional Market Estimates & Trend Analysis

9.1. Global Market Regional Snapshot, 2025 & 2035
9.2. North America

9.2.1. Market Revenue by Country (U.S., Canada, Mexico), 2022–2035
9.2.2. North America Carrier Screening Market Revenue (US$ Mn) By Medical Conditions, 2022–2035
9.2.3. North America Carrier Screening Market Revenue (US$ Mn) By Type, 2022–2035
9.2.4. North America Carrier Screening Market Revenue (US$ Mn) By Technology, 2022–2035
9.2.5. North America Carrier Screening Market Revenue (US$ Mn) By End Use, 2022–2035

9.3. Europe

9.3.1. Market Revenue by Country, 2022–2035
9.3.2. Europe Carrier Screening Market Revenue (US$ Mn) By Medical Conditions, 2022–2035
9.3.3. Europe Carrier Screening Market Revenue (US$ Mn) By Type, 2022–2035
9.3.4. Europe Carrier Screening Market Revenue (US$ Mn) By Technology, 2022–2035
9.3.5. Europe Carrier Screening Market Revenue (US$ Mn) By End Use, 2022–2035

9.4. Asia Pacific

9.4.1. Market Revenue by Country, 2022–2035
9.4.2. Asia Pacific Carrier Screening Market Revenue (US$ Mn) By Medical Conditions, 2022–2035
9.4.3. Asia Pacific Carrier Screening Market Revenue (US$ Mn) By Type, 2022–2035
9.4.4. Asia Pacific Carrier Screening Market Revenue (US$ Mn) By Technology, 2022–2035
9.4.5. Asia Pacific Carrier Screening Market Revenue (US$ Mn) By End Use, 2022–2035

9.5. Latin America

9.5.1. Market Revenue by Country, 2022–2035
9.5.2. Latin America Carrier Screening Market Revenue (US$ Mn) By Medical Conditions, 2022–2035
9.5.3. Latin America Carrier Screening Market Revenue (US$ Mn) By Type, 2022–2035
9.5.4. Latin America Carrier Screening Market Revenue (US$ Mn) By Technology, 2022–2035
9.5.5. Latin America Carrier Screening Market Revenue (US$ Mn) By End Use, 2022–2035

9.6. Middle East & Africa

9.6.1. Market Revenue by Country, 2022–2035
9.6.2. Middle East & Africa Carrier Screening Market Revenue (US$ Mn) By Medical Conditions, 2022–2035
9.6.3. Middle East & Africa Carrier Screening Market Revenue (US$ Mn) By Type, 2022–2035
9.6.4. Middle East & Africa Carrier Screening Market Revenue (US$ Mn) By Technology, 2022–2035
9.6.5. Middle East & Africa Carrier Screening Market Revenue (US$ Mn) By End Use, 2022–2035

Chapter 10. Competitive Landscape

10.1. Key Strategic Developments (Mergers & Acquisitions, Partnerships, Product Launches)
10.2. Market Share Analysis, 2026

10.3. Company Profiles (10 Players)

10.3.1. Myriad Genetics, Inc.
10.3.2. Natera, Inc.
10.3.3. Laboratory Corporation of America Holdings / Labcorp
10.3.4. Quest Diagnostics Incorporated
10.3.5. BGI Genomics Co., Ltd.
10.3.6. CENTOGENE GmbH
10.3.7. MedGenome Labs Ltd.
10.3.8. GeneDx
10.3.9. Fulgent Genetics, Inc.
10.3.10. Thermo Fisher Scientific Inc.
10.3.11. Illumina, Inc.
10.3.12. CooperSurgical / CooperGenomics
10.3.13. Invitae / Labcorp
10.3.14. Otogenetics Corporation
10.3.15. ATS GeneTech Pvt. Ltd.
10.3.16. Other Emerging Players

Research Design and Approach

This study employed a multi-step, mixed-method research approach that integrates:

  • Secondary research
  • Primary research
  • Data triangulation
  • Hybrid top-down and bottom-up modelling
  • Forecasting and scenario analysis

This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.

Secondary Research

Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.

Sources Consulted

Secondary data for the market study was gathered from multiple credible sources, including:

  • Government databases, regulatory bodies, and public institutions
  • International organizations (WHO, OECD, IMF, World Bank, etc.)
  • Commercial and paid databases
  • Industry associations, trade publications, and technical journals
  • Company annual reports, investor presentations, press releases, and SEC filings
  • Academic research papers, patents, and scientific literature
  • Previous market research publications and syndicated reports

These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.

Secondary Research

Primary Research

Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.

Stakeholders Interviewed

Primary interviews for this study involved:

  • Manufacturers and suppliers in the market value chain
  • Distributors, channel partners, and integrators
  • End-users / customers (e.g., hospitals, labs, enterprises, consumers, etc., depending on the market)
  • Industry experts, technology specialists, consultants, and regulatory professionals
  • Senior executives (CEOs, CTOs, VPs, Directors) and product managers

Interview Process

Interviews were conducted via:

  • Structured and semi-structured questionnaires
  • Telephonic and video interactions
  • Email correspondences
  • Expert consultation sessions

Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.

Data Processing, Normalization, and Validation

All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.

The data validation process included:

  • Standardization of units (currency conversions, volume units, inflation adjustments)
  • Cross-verification of data points across multiple secondary sources
  • Normalization of inconsistent datasets
  • Identification and resolution of data gaps
  • Outlier detection and removal through algorithmic and manual checks
  • Plausibility and coherence checks across segments and geographies

This ensured that the dataset used for modelling was clean, robust, and reliable.

Market Size Estimation and Data Triangulation

Bottom-Up Approach

The bottom-up approach involved aggregating segment-level data, such as:

  • Company revenues
  • Product-level sales
  • Installed base/usage volumes
  • Adoption and penetration rates
  • Pricing analysis

This method was primarily used when detailed micro-level market data were available.

Bottom Up Approach

Top-Down Approach

The top-down approach used macro-level indicators:

  • Parent market benchmarks
  • Global/regional industry trends
  • Economic indicators (GDP, demographics, spending patterns)
  • Penetration and usage ratios

This approach was used for segments where granular data were limited or inconsistent.

Hybrid Triangulation Approach

To ensure accuracy, a triangulated hybrid model was used. This included:

  • Reconciling top-down and bottom-up estimates
  • Cross-checking revenues, volumes, and pricing assumptions
  • Incorporating expert insights to validate segment splits and adoption rates

This multi-angle validation yielded the final market size.

Forecasting Framework and Scenario Modelling

Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.

Forecasting Methods

  • Time-series modelling
  • S-curve and diffusion models (for emerging technologies)
  • Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes)
  • Price elasticity models
  • Market maturity and lifecycle-based projections

Scenario Analysis

Given inherent uncertainties, three scenarios were constructed:

  • Base-Case Scenario: Expected trajectory under current conditions
  • Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds
  • Conservative Scenario: Slow adoption, regulatory delays, economic constraints

Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.

Request Customization

Add countries, segments, company profiles, or extend forecast — free 10% customization with purchase.

Customize This Report →

Enquire Before Buying

Speak with our analyst team about scope, methodology, pricing, or deliverable formats.

Enquire Now →

Frequently Asked Questions

What is the Carrier Screening Market Size?

Carrier Screening Market Size is valued at USD 1.49 Bn in 2025 and is predicted to reach USD 5.16 Bn by the year 2035

What is the Carrier Screening Market Growth?

Carrier Screening Market is likely to grow with at a 13.4% CAGR during the forecast period for 2026 to 2035.

Who are the key players in the Carrier Screening Market?

Myriad Genetics, Inc., BGI Genomics, Illumina, Inc., Thermo Fisher Scientific, Inc, F. Hoffmann-La Roche Ltd, Laboratory Corporation of America Holdings (LabCorp), Otogenetics Corporation, MedGenome, GeneTech (ATS Genetech Pvt Ltd), CENTOGENE GmbH

What are the key segments of the Carrier Screening Market?

Carrier Screening Market is segmented into Medical Conditions, Type, Technology, End-Use and By Region

Which region is leading the Carrier Screening Market?

North America region is leading the Carrier Screening Market.

FREE SAMPLE REPORT

Get Your Market Report Sample

See the data, methodology, and competitive landscape preview & delivered to your inbox shortly.

Check your inbox shortly after submitting. If you don't see our email, please check your External, Spam, Junk, or Promotions folder.

Trusted by Sartorius, L'Oreal, Fujifilm & 370+ organizations

KOL-Validated Research Analyst-Built Models Direct Analyst Access
Send me Sample Report Request for Customization